Citing “radiation risks,” China has ordered the removal of full-body X-ray scanners at airports and railway stations.
In an urgent document sent to the Department of Environmental Protection of Sichuan Province on Oct. 10 and published on Oct. 12, the Ministry of Environmental Protection urged DEPSP to strengthen law enforcement and stop producing, selling and using full-body X-ray scanners without authorization to ensure the safety of the people.
The document came after some travelers complained about radiation hazards and the use of full-body security scanners at airports and railways stations in Sichuan’s capital city Chengdu and other areas.
After receiving the MEP document, the DEPSP said that the Chengdu Shuangliu International Airport is suspected of violating environmental protection regulations by using the devices. The DEPSP has ordered the airport to remove the full-body X-ray scanners and asked Chengdu city to investigate the issue.
The MEP found that the radiation dose that each person receives from the scanner has just a small effect on the human body, but as China has a large population and heavy travel volume, wide use of full-body X-ray scanners at airports, railways stations and ports is not appropriate. The MEP said that ionizing radiation devices should not be used to screen humans on a large scale.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
